| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.4 |